Peng Kai Ong

Peng Kai Ong

Auto-generated profile, based on publicly available information

Peng Kai Ong

National University of Singapore

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2013 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
POPeng Kai Ong
Peng Kai Ong
BMBenoît Melchior
Benoît Melchior
Yuri Chaves MartinsYuri Chaves Martins
Yuri Chaves Martins
AHAnthony Hofer
Anthony Hofer
POPamela Orjuela-Sánchez
Pamela Orjuela-Sánchez
LCLeonardo J. M. Carvalho
Leonardo J. M. Carvalho
Cerebrovascular dysfunction plays a key role in the pathogenesis of cerebral malaria. In experimental cerebral malaria (ECM) induced by Plasmodium berghei ANKA, cerebrovascular dysfunction characterized by vascular constriction, occlusion and damage results in impaired perfusion and reduced cerebral blood flow and oxygenation, and has been linked to low nitric oxide (NO) bioavailability. Here, we directly assessed cerebrovascular function in ECM using a novel cranial window method for intravital microscopy of the pial microcirculation and probed the role of NOS isoforms and phosphorylation patterns in the impaired vascular responses. We show that pial arteriolar responses to endothelial NOS (eNOS) and neuronal NOS (nNOS) agonists (Acetylcholine (ACh) and N-Methyl-D-Aspartate (NMDA)) were blunted in mice with ECM, and could be partially recovered by exogenous supplementation of tetrahydrobiopterin (BH4). Pial arterioles in non-ECM mice infected by Plasmodium berghei NK65 remained relatively responsive to the agonists and were not significantly affected by BH4 treatment. These findings, together with the observed blunting of NO production upon stimulation by the agonists, decrease in total NOS activity, augmentation of lipid peroxidation levels, upregulation of eNOS protein expression, and increase in eNOS and nNOS monomerization in the brain during ECM development strongly indicate a state of eNOS/nNOS uncoupling likely mediated by oxidative stress. Furthermore, the downregulation of Serine 1176 (S1176) phosphorylation of eNOS, which correlated with a decrease in cerebrovascular wall shear stress, implicates hemorheological disturbances in eNOS dysfunction in ECM. Finally, pial arterioles responded to superfusion with the NO donor, S-Nitroso-L-glutathione (GSNO), but with decreased intensity, indicating that not only NO production but also signaling is perturbed during ECM. Therefore, the pathological impairment of eNOS and nNOS functions contribute importantly to cerebrovascular dysfunction in ECM and the recovery of intrinsic functionality of NOS to increase NO bioavailability and restore vascular health represents a target for ECM treatment. Cerebrovascular dysfunction plays a key role in the pathogenesis of murine cerebral malaria (CM). Low nitric oxide (NO) bioavailability has been attributed as a cause of the dysfunction. However, it is unclear if the NO deficit could be inflicted by decreased NO production from its enzymatic sources (NO synthases (NOS)) in the brain. Here, we applied a novel cranial window method to elucidate the role of NOS in cerebrovascular dysfunction in murine CM. We found a state of endothelial NOS (eNOS) and neuronal NOS (nNOS) dysfunctions that are detrimental to cerebroarteriolar reactivity. Supplementation of tetrahydrobiopterin (BH4), a cofactor for NOS activation, ameliorates this effect. Supported by experimental findings on the downregulation of total NOS activity as well as the enhancement of oxidative stress, eNOS protein expression and conformational eNOS and nNOS inactivation in brains of mice with CM, we identified eNOS/nNOS uncoupling as a potential mechanism responsible for the NOS dysfunction. In addition, we discovered a downregulation of eNOS phosphorylation at its Serine residue (S1176) that can possibly decrease eNOS activity and exacerbate eNOS dysfunction. Our study provides new insights on the involvement of NOS in cerebrovascular dysfunction during CM and suggests NOS as a therapeutic target for CM.

23 July 2010 in Annals of Biomedical Engineering
Verified
Journal Article
Open access
PDF file
BNBumseok Namgung
Bumseok Namgung
POPeng Kai Ong
Peng Kai Ong
PJPaul C. Johnson
Paul C. Johnson
SKSangho Kim
Sangho Kim
Relationship between a cell-free layer and wall shear stress (WSS) in small arterioles has been of interest in microcirculatory research. However, influence of temporal variation in the cell-free layer width on the WSS in vivo has not been fully elucidated. In this study, we tested the hypothesis that the layer variation would increase the WSS, and this effect would be enhanced by red blood cell aggregation. The cell-free layer width in arterioles (29.5–67.1 μm ID) in rat cremaster muscles were obtained with a high-speed video camera, and the layer width data were introduced into WSS estimation. Dextran 500 was administrated to elevate the aggregation level of red blood cells to those seen in normal human blood. The variation of the layer was quantified by the variability (coefficient of variation), and its effect on WSS was studied under normal and reduced flow conditions. We found that the dextran-induced red blood cell aggregation significantly elevated the variability (p < 0.01) at low pseudoshear rates of 9.2 ± 0.6 s−1. The WSS estimated without taking account of the variability showed underestimation of its value than that of with consideration of the variability under all flow conditions, and this effect became more pronounced with increasing the variability. The variation of the cell-free layer should, therefore, be considered in the determination of the WSS particularly in the presence of red blood cell aggregation under reduced flow condition.

1 March 2012 in Microvascular Research
Verified
Journal Article
Closed access
POPeng Kai Ong
Peng Kai Ong
SJSwati Jain
Swati Jain
SKSangho Kim
Sangho Kim

1 June 2009 in Journal of Mechanical Science and Technology
Verified
Journal Article
Closed access
PDF file
SKSangho Kim
Sangho Kim
BNBumseok Namgung
Bumseok Namgung
POPeng Kai Ong
Peng Kai Ong
YCYoung I. Cho
Young I. Cho
KCKeyoung Jin Chun
Keyoung Jin Chun
DLDohyung Lim
Dohyung Lim

17 May 2011 in Microcirculation
Verified
Journal Article
Closed access
PDF file
POPeng Kai Ong
Peng Kai Ong
SJSwati Jain
Swati Jain
BNBumseok Namgung
Bumseok Namgung
YWYeon I. Woo
Yeon I. Woo
SKSangho Kim
Sangho Kim

24 April 2013 in Malaria Journal
Verified
Journal Article
Open access
PDF file
Yuri Chaves MartinsYuri Chaves Martins
Yuri Chaves Martins
LCLeah Clemmer
Leah Clemmer
POPamela Orjuela-Sánchez
Pamela Orjuela-Sánchez
GZGraziela M Zanini
Graziela M Zanini
POPeng Kai Ong
Peng Kai Ong
LCLeonardo Jm Carvalho
Leonardo Jm Carvalho
Human cerebral malaria (HCM) is a life-threatening complication caused by Plasmodium falciparum infection that continues to be a major global health problem despite optimal anti-malarial treatment. In the experimental model of cerebral malaria (ECM) by Plasmodium berghei ANKA, bolus administration of nimodipine at high doses together with artemether, increases survival of mice with ECM. However, the dose and administration route used is associated with cardiovascular side effects such as hypotension and bradycardia in humans and mice, which could preclude its potential use as adjunctive treatment in HCM.